Hernia Repair Devices MarketThe global Hernia Repair Devices Market is set for significant growth, with its valuation projected to rise from USD 5.0 billion in 2023 to USD 12.3 billion by 2033. This ...

Liquid Biopsy MarketThe global liquid biopsy market is on a trajectory of unprecedented growth, with revenues projected to soar from USD 1,538.3 million in 2023 to an astounding USD 10,938.6 million ...

The global surgical site infection prevention market size was US$ 4.6 billion in 2021. The global surgical site infection prevention market is forecast to grow to US$ 7.85 billion by 2030, registering ...

Skin antisepsis with iodine povacrylex in alcohol resulted in fewer surgical-site infections than with chlorhexidine ...

The global hernia repair market size was US$ 3.9 billion in 2021. The global hernia repair market is forecast to reach US$ 6.7 billion by 2030, registering a compound annual growth rate (CAGR) of 6.1% ...

BERWYN, PA — Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has reported encouraging results from a minipig Dose Range Finding (DRF) study for Probudur, its long-acting liposomal bupivacaine injection.

Virpax announces positive results from minipig Dose Range Finding study for Probudur: Berwyn, Pennsylvania Monday, November 25, 2024, 18:00 Hrs [IST] Virpax Pharmaceuticals, Inc., ...

The Chandigarh Bench of the Central Administrative Tribunal has quashed an order passed by the Chief Medical Superintendent, Northern Railway Divisional Hospital, Ambala Cantt, refusing to reimburse ...

Virpax Pharmaceuticals (VRPX) announced results from a minipig dose range finding, or DRF, study for Probudur. Probudur is the company’s ...

Virpax Pharmaceuticals, Inc. ("Virpax" or the "Company"), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) ...

Glaucoma encompasses a heterogeneous group of eye diseases associated with progressive loss of optic nerve fibers, with ...